EQUINOX/ SI0031117813 /
06/01/2025 12:34:21 | Chg. - | Volume | Bid15:27:04 | Ask15:27:04 | High | Low |
---|---|---|---|---|---|---|
56.00EUR | - | 45 Turnover: 2,563.50 |
-Bid Size: - | -Ask Size: - | 58.00 | 56.00 |
Newsfile Corp
03/10/2024
Resourcing Tomorrow Announces Shortlist of Nominees for Prestigious Outstanding Achievement Awards
Newsfile Corp
05/09/2024
Dr Neil Paulvin Featured as Speaker at Equinox Hotel's Global Sleep Symposium
GlobeNewswire
27/08/2024
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
22/08/2024
Mount Sinai Health System Partners with Pickleball Organization CityPickle to Promote Health, Physic...
GlobeNewswire
20/08/2024
Navios Maritime Partners L.P. Reports Financial Results for the Second Quarter and Six Months Ended ...
GlobeNewswire
16/08/2024
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
08/08/2024
EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire
07/08/2024
EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corpora...
GlobeNewswire
06/08/2024
Martinrea International Inc. Reports Strong Second Quarter Results and Declares Dividend
GlobeNewswire
16/07/2024
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
09/07/2024
Smart for Life Announces Appointment of Jessica Walters as Chief Marketing Officer
GlobeNewswire
26/06/2024
EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulat...
GlobeNewswire
24/06/2024
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
21/06/2024
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
17/06/2024
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
17/06/2024
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
14/06/2024
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
13/06/2024
Achieve Extraordinary Detection With the X-TERRA ELITE and X-TERRA ELITE Expedition Pack From Minela...
GlobeNewswire
10/06/2024
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
06/06/2024
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
05/06/2024
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference